NDRG2 gene expression in B16F10 melanoma cells restrains melanogenesis via inhibition of Mitf expression

Pigment Cell and Melanoma Research

Volumn 21, Issue 6, 2008, Pages 653-664

  Kim, Aeyung ^a   Yang, Young ^a   Lee, Myeong Sok ^a   Yoo, Young Do ^b   Lee, Hee Gu ^c   Lim, Jong Seok ^a  

^a Sookmyung Women's University   (South Korea)

^b Korea University College of Medicine   (South Korea)

^c Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

Author keywords

cAMP; Melanogenesis; Mitf; NDRG2; TCF catenin

Indexed keywords

BETA CATENIN; CYCLIC AMP; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; MONOPHENOL MONOOXYGENASE;

ANIMAL CELL; ARTICLE; CANCER GROWTH; CELL CYCLE REGULATION; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; GENE EXPRESSION REGULATION; MELANOGENESIS; MELANOMA; NDRG 2 GENE; NONHUMAN; ONCOGENE C MYB; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SKIN PIGMENTATION; TUMOR SUPPRESSOR GENE;

1-METHYL-3-ISOBUTYLXANTHINE; ALPHA-MSH; ANIMALS; BETA CATENIN; BLOTTING, WESTERN; CYCLIC AMP; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; GENE EXPRESSION REGULATION, NEOPLASTIC; HORMONES; INTRAMOLECULAR OXIDOREDUCTASES; LUCIFERASES; MELANINS; MELANOCYTES; MELANOMA, EXPERIMENTAL; MEMBRANE GLYCOPROTEINS; MICE; MICROPHTHALMIA-ASSOCIATED TRANSCRIPTION FACTOR; MONOPHENOL MONOOXYGENASE; OXIDOREDUCTASES; PHOSPHODIESTERASE INHIBITORS; PHOSPHORYLATION; PROMOTER REGIONS, GENETIC; PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; TCF TRANSCRIPTION FACTORS;

EID: 56249106532     PISSN: None     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1755-148X.2008.00503.x     Document Type: Article

References (42)

1. Abe, H., Ohya, N., Yamamoto, K.F., Shibuya, T., Arichi, S. Odashima, S. (1987). Effects of glycyrrhizin and glycyrrhetinic acid on growth and melanogenesis in cultured B16 melanoma cells. Eur. J. Cancer Clin. Oncol. 23, 1549 1555.
2. Barker, N. Clevers, H. (2000). Catenins, Wnt signaling and cancer. Bioessays 22, 961 965.
3. Bertolotto, C., Abbe, P., Hemesath, T.J., Bille, K., Fisher, D.E., Ortonne, J.P. Ballotti, R. (1998). Microphthalmia gene product as a signal transducer in cAMP-induced differentiation of melanocytes. J. Cell Biol. 142, 827 835.
4. Busca, R. Ballotti, R. (2000). Cyclic AMP a key messenger in the regulation of skin pigmentation. Pigment Cell Res. 13, 60 69.
5. Cadigan, K.M. Nusse, R. (1997). Wnt signaling: a common theme in animal development. Genes Dev. 11, 3286 3305.
6. Carreira, S., Goodall, J., Denat, L., Rodriquez, M., Nuciforo, P., Hoek, K.S., Testori, A., Larue, L. Goding, C.R. (2006). Mitf regulation of Dia1 controls melanoma proliferation and invasiveness. Genes Dev. 20, 3426 3439.
7. Chang, K.L. Folpe, A.L. (2001). Diagnostic utility of microphthalmia transcription factor in malignant melanoma and other tumors. Adv. Anat. Pathol. 8, 273 275.
8. Choi, S.C., Kim, K.D., Kim, J.T., Kim, J.W., Yoon, D.Y., Choe, Y.K., Chang, Y.S., Paik, S.G. Lim, J.S. (2003). Expression and regulation of NDRG2 (N-myc downstream regulated gene 2) during the differentiation of dendritic cells. FEBS Lett. 553, 413 418.
9. Choi, S.C., Yoon, S.R., Park, Y.P., Song, E.Y., Kim, J.W., Kim, W.H., Yang, Y., Lim, J.S. Lee, H.G. (2007). Expression of NDRG2 is related to tumor progression and survival of gastric cancer patients through Fas-mediated cell death. Exp. Mol. Med. 39, 705 714.
10. Deng, Y., Yao, L., Chau, L. et al. (2003). N-Myc downstream-regulated gene 2 (NDRG2) inhibits glioblastoma cell proliferation. Int. J. Cancer 106, 342 347.
11. Dunn, K.J., Williams, B.O., Li, Y. Pavan, W.J. (2000). Neural crest-directed gene transfer demonstrates Wnt1 role in melanocyte expansion and differentiation during mouse development. Proc. Natl Acad. Sci. USA 97, 10050 10055.
12. Englaro, W., Rezzonico, R., Durand-Clement, M., Lallemand, D., Ortonne, J.P. Ballotti, R. (1995). Mitogen-activated protein kinase pathway and AP-1 are activated during cAMP-induced melanogenesis in B-16 melanoma cells. J. Biol. Chem. 270, 24315 24320.
13. Friedmann, P.S. Gilchrest, B.A. (1987). Ultraviolet radiation directly induces pigment production by cultured human melanocytes. J. Cell. Physiol. 133, 88 94.
14. Garraway, L.A., Widlund, H.R., Rubin, M.A. et al. (2005). Intergrative genomic analysis identify MITF as a lineage survival oncogene amplified in malignant melanoma. Nature 436, 117 122.
15. Goding, C.R. (2000). Mitf from neural crest to melanoma: signal transduction and transcription in the melanocyte lineage. Genes Dev. 14, 1712 7128.
16. Hearing, V.J. Jimenez, M. (1989). Analysis of mammalian pigmentation at the molecular level. Pigment Cell Res. 2, 75 85.
17. Hedgepeth, C.M., Conrad, L.J., Zhang, J., Huang, H.C., Lee, V.M. Klein, P.S. (1997). Activation of the Wnt signaling pathway: a molecular mechanism for lithium action. Dev. Biol. 185, 82 91.
18. Hunt, G., Todd, C., Cresswell, J.E. Thody, A.J. (1994). Alpha-melanocyte stimulating hormone and its analogue Nle4DPhe7 alpha-MSH affect morphology, tyrosinase activity and melanogenesis in cultured human melanocytes. J. Cell Sci. 107, 205 211.
19. Jin, E.J. Thibaudeau, G. (1999). Effects of lithium on pigmentation in the embryonic zebrafish (Brachydanio rerio). Biochim. Biophys. Acta. 1449, 93 99.
20. Kang, H.Y., Jung, E.S., Cho, Y. Kang, W.H. (2002). Lithium chloride increases pigmentation of melanoma cells by interfering with the inositol phosphate pathway. Arch. Dermatol. Res. 294, 426 429.
21. Khaled, M., Larribere, L., Bille, K., Aberdam, E., Ortonne, J.P., Ballotti, R. Bertolotto, C. (2002). Glycogen synthase kinase 3beta is activated by cAMP and plays an active role in the regulation of melanogenesis. J. Biol. Chem. 277, 33690 33697.
22. Khaled, M., Larribere, L., Bille, K., Ortonne, J.P., Ballotti, R. Bertolotto, C. (2003). Microphthalmia associated transcription factor is a target of the phosphatidylinositol-3-kinase pathway. J. Invest. Dermatol. 121, 831 836.
23. King, R., Weilbaecher, K.N., McGill, G., Cooley, E., Mihm, M. Fisher, D.E. (1999). Microphthalmia transcription factor. A sensitive and specific melanocytes marker for melanoma diagnosis. Am. J. Pathol. 155, 731 738.
24. Kovacevic, Z. Richardson, D.R. (2006). The metastasis suppressor, Ndrg-1: a new ally in the fight against cancer. Carcinogenesis 27, 2355 2366.
25. Lee, J., Jung, E., Park, J. et al. (2005). Glycyrrhizin induces melanogenesis by elevating a cAMP level in b16 melanoma cells. J. Invest. Dermatol. 124, 405 411.
26. Lusis, E.A., Watson, M.A., Chicoine, M.R., Lyman, M., Roerig, P., Reifenberger, G., Gutmann, D.H. Perry, A. (2005). Integrative genomic analysis identifies NDRG2 as a candidate tumor suppressor gene frequently inactivated in clinically aggressive meningioma. Cancer Res. 65, 7121 7126.
27. Park, H.Y. Gilchrest, B.A. (1999). Signaling pathways mediating melanogenesis. Cell Mol. Biol. (Noisy-le-grand) 45, 919 930.
28. Park, Y., Shon, S.K., Kim, A., Kim, K.I., Yang, Y., Cho, D.H., Lee, M.S. Lim, J.S. (2007). SOCS1 induced by NDRG2 expression negatively regulates STAT3 activation in breast cancer cells. Biochem. Biophysic. Res. Comm. 363, 361 367.
29. Parvez, S., Kang, M., Chung, H.S., Cho, C., Hong, M.C., Shin, M.K. Bae, H. (2006). Survey and mechanism of skin depigmenting and lightening agents. Phytother. Res. 20, 921 934.
30. Patapoutian, A. Reichardt, L.F. (2000). Roles of Wnt proteins in neural development and maintenance. Curr. Opin. Neurobiol. 10, 392 399.
31. Piquemal, D., Joulia, D., Balaguer, P., Basset, A., Marti, J. Commes, T. (1999). Differential expression of the RTP/Drg1/Ndr1 gene product in proliferating and growth arrested cells. Biochim. Biophys. Acta 1450, 364 373.
32. Qu, X., Zhai, Y., Wei, H., Zhang, C., Xing, G., Yu, Y. He, F. (2002). Characterization and expression of three novel differentiation-related genes belong to the human NDRG gene family. Mol. Cell. Biochem. 229, 35 44.
33. Salti, G.I., Manougian, T., Farolan, M., Shilkaitis, A., Majumdar, D. Das Gupta, T.K. (2000). Microphthalmia transcription factor: a new prognostic marker in intermediate-thickness cutaneous malignant melanoma. Cancer Res. 60, 5012 5016.
34. Takeda, K., Yasumoto, K., Takada, R., Takada, S., Watanabe, K., Udono, T., Saito, H., Takahashi, K. Shibahara, S. (2000). Induction of melanocyte-specific microphthalmia-associated transcription factor by Wnt-3a. J. Biol. Chem. 275, 14013 14016.
35. Thody, A.J. Graham, A. (1998). Does alpha-MSH have a role in regulating skin pigmentation in humans? Pigment Cell Res. 11, 265 274.
36. Ulrix, W., Swinnen, J.V., Heyns, W. Verhoeven, G. (1999). The differentiation-related gene 1, Drg1, is markedly upregulated by androgens in LNCaP prostatic adenocarcinoma cells. FEBS Lett. 455, 23 26.
37. Vachtenheim, J. Borovansky, J. (2004). Micropthalmia transcription factor: a specific marker for malignant melanoma. Prague Med. Rep. 105, 318 324.
38. Widlund, H.R., Horstmann, M.A., Price, E.R., Cui, J., Lessnick, S.L., Wu, M., He, X. Fisher, D.E. (2002). β-catenin-induced melanoma growth requires the downstream target Microphthalmia-associated transcription factor. J. Cell Biol. 158, 1079 1087.
39. Yasumoto, K., Yokoyama, K., Takahashi, K., Tomita, Y. Shibahara, S. (1997). Functional analysis of microphthalmia-associated transcription factor in pigment cell-specific transcription of the human Tyrosinase family genes. J. Biol. Chem. 272, 503 509.
40. Yasumoto, K., Takeda, K., Saito, H., Watanabe, K., Takahashi, K. Shibahara, S. (2002). Microphthalmia-associated transcription factor interacts with LEF-1, a mediator of Wnt signaling. EMBO J. 21, 2703 2714.
41. Yavuzer, U., Keenan, E., Lowings, P., Vachtenheim, J., Currie, G. Goding, C.R. (1995). The Microphthalmia gene product interacts with the retinoblastoma protein in vitro and is a target for deregulation of melanocyte-specific transcription. Oncogene 10, 123 134.
42. Zhou, R.H., Kokame, K., Tsukamoto, Y., Yutani, C., Kato, H. Miyata, T. (2001). Characterization of the human NDRG gene family: a newly identified member, NDRG4, is specifically expressed in brain and heart. Genomics 73, 86 97.